glp-1 and type 1 diabetes Mechanisms of action of GLP-1RA Improved Heart and Kidney Outcomes
Description
Additionally, they reduce insulin synthesis and it is thought that they reduce cell mass through the induction of beta cell apoptosis
Initial treatment phase (weeks 14): During the starting dose of 0.25 mg weekly, patients commonly experience mild to moderate nausea, occasional sulphur burps, and changes in bowel habits
AV Preeminent Attorney Judicial Edition by (2017-present) Top Ranked Lawyer by Martindale-Hubbell and ALM (2019-2022)
On the other hand, GLP-1RAs are associated with neuroprotective properties and reductions in ischemic risk
Frontiers in Pharmacology, 16, 1602018
